A phase III trial assessing the efficacy and safety of Grazax in subjects with seasonal grass pollen induced rhinoconjunctivitis with or without asthma
Latest Information Update: 27 Jan 2015
At a glance
- Drugs Timothy grass pollen allergen extract (Grastek) (Primary)
- Indications Grass pollen hypersensitivity; Rhinoconjunctivitis
- Focus Therapeutic Use
- Sponsors ALK-Abello
- 25 Jan 2007 New trial record.